HSV-1 Viral Oncolysis and Molecular Imaging with PET
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
175-180
Author(s):
Darshini Kuruppu, Jon D. Dorfman and Kenneth K. Tanabe
Oncolytic Viruses Driven by Tumor-Specific Promoters
Journal:
Current Cancer Drug Targets
Volume:
7
Page:
181-189
Author(s):
Jayson Hardcastle, Kazuhiko Kurozumi, E. Antonio Chiocca and Balveen Kaur
Human Multidrug Transporter ABCG2, a Target for Sensitizing Drug Resistance in Cancer Chemotherapy
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
689-701
Author(s):
Junkang Xu, Hui Peng and Jian Ting Zhang
Editorial [Hot Topic: Targeting the IGF-I Receptor Signaling Pathway:Implications for Human Cancer Therapy (Executive Editors: A. Ciampolillo and F. Giorgino) ]
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
661-662
Author(s):
Anna Ciampolillo and Francesco Giorgino
The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
671-686
Author(s):
Antonino Belfiore
Anti-Apoptotic Actions of Insulin-Like Growth Factors: Lessons from Development and Implications in Neoplastic Cell Transformation
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
687-703
Author(s):
Isabel Varela-Nieto, Markus Hartl, Itziar Gorospe and Yolanda Leon
Crosstalk between IGF Signaling and Steroid Hormone Receptors in Breast Cancer
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
705-717
Author(s):
Diego Sisci and Eva Surmacz
Drug Carriers in Pharmaceutical Design: Promises and Progress
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
761-769
Author(s):
Ranjna C. Dutta
A Role for Milk Proteins and their Peptides in Cancer Prevention
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
813-828
Author(s):
P. W. Parodi
Nucleoprotein-Derived and Unbound Ribonucleosides: Bioactivity and Potential Applications
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
921-932
Author(s):
Dierk Martin and Hans Meisel